摘要
胆碱是一种季铵盐,并作为不同膜磷脂的重要组成部分,有助于细胞膜结构的完整性。含胆碱磷脂(CCPLs)包括磷脂酰胆碱(PC),鞘磷脂(SM),甘磷酸胆碱(GPC)。在大多数真核细胞中,聚碳酸酯 是主要的磷脂。它参与SM合成,胆碱/胆碱代谢物重新生成,和脂肪酸/凝胶的形成。本文综述了化学、生物学和治疗的特点关于分析得出的CCPLs,a)外源CCPLs效应,b)GPC治疗脑胆碱能神经传递的影响,c)神经保护作用GPC单独或与乙酰胆碱酯酶抑制剂在脑血管损伤动物模型的关联,d)胆碱类似物的合成,包括含有短链烷基取代甲基。胞苷二磷酸胆碱和GPC,保护细胞膜,可以在治疗脑血管意外后遗症有帮助。此外,细胞膜破裂还作为一个无论是在急性(中风)和慢性(阿尔茨海默和血管性痴呆)的脑功能障碍的特征。公布的数据都集中到一个更大的程度上的生物合成,细胞生命活动相关的作用,和与胆碱能神经传递的CCPLs至关重要的参与。由发表的临床研究表明了在治疗脑血管和神经退行性疾病方面的可能性。在这些潜在的实际应用药物治疗中,对神经系统疾病的胆碱能损伤可能的活性胆碱衍生物的合成研究领域需要进一步的研究讨论。
关键词: 含胆碱磷脂、脑血管病、甘磷酸胆碱,胞二磷胆碱,胆碱衍生物的合成。
Current Medicinal Chemistry
Title:Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications
Volume: 22 Issue: 38
Author(s): S.K. Tayebati, G. Marucci, C. Santinelli, M. Buccioni and F. Amenta
Affiliation:
关键词: 含胆碱磷脂、脑血管病、甘磷酸胆碱,胞二磷胆碱,胆碱衍生物的合成。
摘要: Choline is a quaternary ammonium salt, and being an essential component of different membrane phospholipids (PLs) contributes to the structural integrity of cell membranes. Choline-containing phospholipids (CCPLs) include phosphatidylcholine (PC), sphingomyelin (SM), and choline alphoscerate (GPC). PC is the major phospholipid in most eukaryotic cells. It is involved in SM synthesis, choline/choline metabolite re-generation, and fatty acid/GPC formation. This paper has reviewed chemical, biological and therapeutic features of CCPLs by analyzing: a) effects of exogenous CCPLs, b) influence of GPC treatment on brain cholinergic neurotransmission, and c) neuroprotective effects of GPC alone or in association with acetylcholinesterase inhibitors in animal models of brain vascular injury, d) synthesis of the choline analogs, containing a short alkyl chain instead of a methyl group. Cytidine-diphosphocholine and GPC, protect cell membranes and could be helpful in the sequelae of cerebrovascular accident treatment. Moreover, cellular membrane breakdown is suggested as a feature of neurodegeneration both in acute (stroke) and in chronic (Alzheimer and vascular dementia) brain disorders. Published data were focused to a larger extent on the biosynthesis, relevant role in cell life, and crucial involvement of CCPLs in cholinergic neurotransmission. The possibility of their use in the treatment of cerebrovascular and neurodegenerative disorders is suggested by published clinical studies. In line with these potential practical applications in pharmacotherapy, the need of further research in the field of the synthesis of new choline derivatives with possible activity in nervous system diseases characterized by cholinergic impairment is discussed.
Export Options
About this article
Cite this article as:
S.K. Tayebati, G. Marucci, C. Santinelli, M. Buccioni and F. Amenta , Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications, Current Medicinal Chemistry 2015; 22 (38) . https://dx.doi.org/10.2174/0929867322666151029104152
DOI https://dx.doi.org/10.2174/0929867322666151029104152 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fluorescent Imaging of Amyloid-β Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for In Vivo Imaging
Current Medicinal Chemistry Voluntary Running and Environmental Enrichment Restores Impaired Hippocampal Neurogenesis in a Triple Transgenic Mouse Model of Alzheimers Disease
Current Alzheimer Research Systems Biology Approaches and Metabolomics for Understanding Japanese Traditional Kampo Medicine
Current Pharmacogenomics and Personalized Medicine Erythrocyte Cytoskeletal-plasma Membrane Protein Network in Rett Syndrome: Effects of ω-3 Polyunsaturated Fatty Acids
Current Proteomics Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Antidepressant-Like Activity of Fish Oil, with and Without Fluoxetine, in Two Behavioral Despair Paradigms in Experimental Mice
Current Pharmacogenomics and Personalized Medicine Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery Dual Functional Small Molecule Probes as Fluorophore and Ligand for Misfolding Proteins
Current Organic Chemistry Withanolides: Biologically Active Constituents in the Treatment of Alzheimer’s Disease
Medicinal Chemistry Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System
Current Neuropharmacology A Review of the Carbapenems in Clinical Use and Clinical Trials
Recent Patents on Anti-Infective Drug Discovery The Promise of Slow Down Ageing May Come from Curcumin
Current Pharmaceutical Design A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors
Current Topics in Medicinal Chemistry Dynamics of Nicotinic Acetylcholine Receptors and Receptor-Associated Proteins at the Vertebrate Neuromuscular Junction
Current Alzheimer Research FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Porphyromonas gingivalis Mediated Periodontal Disease and Atherosclerosis:Disparate Diseases with Commonalities in Pathogenesis Through TLRs
Current Pharmaceutical Design Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders
Current Pharmaceutical Design Novel Therapeutic Approach for Autism Spectrum Disorder: Focus on SHANK3
Current Neuropharmacology Treatment Strategies of Age-Related Memory Dysfunction by Modulation of Neuronal Plasticity
Mini-Reviews in Medicinal Chemistry Neuromodulation of Hippocampal Synaptic Plasticity, Learning, and Memory by Noradrenaline
Central Nervous System Agents in Medicinal Chemistry